Purchases and Sales Made in Q3 2022 in Belite Bio, Inc (BLTE)
This table provides information about the institutional ownership of Belite Bio, Inc (BLTE) during Q3 2022. The information is specifically focused on institutions that hold shares of BELITE BIO, INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
18.3KNew |
$413K - $806K
|
18.3K
$1.08M
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
10.6KNew |
$239K - $467K
|
10.6K
$623K
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
7.4KNew |
$167K - $326K
|
7.4K
$435K
|
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
7.26KNew |
$164K - $320K
|
7.26K
$427K
|
|
|
Nov 03, 2022
Q3 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
6.66KNew |
$150K - $293K
|
6.66K
$391K
|
|
|
Nov 14, 2022
Q3 2022
|
Atria Wealth Solutions, Inc.
New York, NY |
BUY
|
- |
4.74K+ 9.59% |
$107K - $209K
|
54.2K
$3.19M
|
|
|
Nov 14, 2022
Q3 2022
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
3.8K+ 57.26% |
$85.8K - $167K
|
10.4K
$614K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|